Alps Advisors Inc
- SEC CIK
- 0001376113
- Latest filing
- Jul 29, 2026
BCRX holding history
Biocryst Pharmaceuticals Inc in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BCRX overviewAll 13F holders of BCRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 317,960
- Value
- $3.18M
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 317,960 | $3.18M | <0.1% | +257,710+427.7% | Added | Holders |
| Q1 2026 | 60,250 | $573.6K | <0.1% | +60,250 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −101,125−100.0% | Sold out | Holders |
| Q3 2025 | 101,125 | $767.5K | <0.1% | −11,710−10.4% | Reduced | Holders |
| Q2 2025 | 112,835 | $1.01M | <0.1% | −40,150−26.2% | Reduced | Holders |
| Q1 2025 | 152,985 | $1.15M | <0.1% | −14,507−8.7% | Reduced | Holders |
| Q4 2024 | 167,492 | $1.26M | <0.1% | +9,382+5.9% | Added | Holders |
| Q3 2024 | 158,110 | $1.20M | <0.1% | −2,893−1.8% | Reduced | Holders |
| Q2 2024 | 161,003 | $995.0K | <0.1% | +15,597+10.7% | Added | Holders |
| Q1 2024 | 145,406 | $738.7K | <0.1% | +7,305+5.3% | Added | Holders |
| Q4 2023 | 138,101 | $827.2K | <0.1% | −1,749−1.3% | Reduced | Holders |
| Q3 2023 | 139,850 | $990.1K | <0.1% | +972+0.7% | Added | Holders |
| Q2 2023 | 138,878 | $977.7K | <0.1% | +16,060+13.1% | Added | Holders |
| Q1 2023 | 122,818 | $1.02M | <0.1% | −3,555−2.8% | Reduced | Holders |
| Q4 2022 | 126,373 | $1.45M | <0.1% | +24,834+24.5% | Added | Holders |
| Q3 2022 | 101,539 | $1.28M | <0.1% | −8,576−7.8% | Reduced | Holders |
| Q2 2022 | 110,115 | $1.17M | <0.1% | +110,115 | New | Holders |